Literature DB >> 12944921

Use of adeno-associated viral vector for delivery of small interfering RNA.

Raghuvir S Tomar1, Hittu Matta, Preet M Chaudhary.   

Abstract

Post-transcriptional gene silencing by small interfering RNAs (siRNAs) is rapidly becoming a powerful tool for genetic analysis of mammalian cells. Delivery of siRNA into mammalian cells is usually achieved via the transfection of double-stranded oligonucleotides or plasmids encoding RNA polymerase III promoter-driven small hairpin RNA. Recently, retroviral vectors have been used for siRNA delivery, which overcome the problem of poor transfection efficiency seen with the plasmid-based systems. However, retroviral vectors have several limitations, such as the need for active cell division for gene transduction, oncogenic potential, low titers and gene silencing. In this report, we have adapted a commercially available adenoassociated virus (AAV) vector for siRNA delivery into mammalian cells. We demonstrate the ability of this modified vector to deliver efficiently siRNA into HeLa S3 cells and downregulate p53 and caspase 8 expression. Our results suggest that AAV-based vectors are efficient vectors for the delivery of siRNA into mammalian cells. Based on the known ability of these vectors to infect both dividing and nondividing cells, their use as a therapeutic tool for the delivery of siRNA deserves further study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12944921     DOI: 10.1038/sj.onc.1206733

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  36 in total

1.  CRE recombinase-inducible RNA interference mediated by lentiviral vectors.

Authors:  Gustavo Tiscornia; Vinay Tergaonkar; Francesco Galimi; Inder M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-30       Impact factor: 11.205

Review 2.  Induction of RNA interference in dendritic cells.

Authors:  Mu Li; Hua Qian; Thomas E Ichim; Wei-Wen Ge; Igor A Popov; Katarzyna Rycerz; John Neu; David White; Robert Zhong; Wei-Ping Min
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

3.  Device-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulation.

Authors:  Hironobu Takahashi; Yuwei Wang; David W Grainger
Journal:  J Control Release       Date:  2010-08-19       Impact factor: 9.776

4.  Streptococcal pyrogenic exotoxin B-induced apoptosis in a549 cells is mediated by a receptor- and mitochondrion-dependent pathway.

Authors:  Wan-Hua Tsai; Chia-Wen Chang; Woei-Jer Chuang; Yee-Shin Lin; Jiunn-Jong Wu; Ching-Chuan Liu; Wen-Tsan Chang; Ming T Lin
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

5.  An inducible T7 RNA polymerase-dependent plasmid system.

Authors:  Matthias Hamdorf; Heide Muckenfuss; Ulrich Tschulena; Stephan Pleschka; Ralf Sanzenbacher; Klaus Cichutek; Egbert Flory
Journal:  Mol Biotechnol       Date:  2006-05       Impact factor: 2.695

Review 6.  Gene modulation for treating liver fibrosis.

Authors:  Kun Cheng; Ram I Mahato
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2007       Impact factor: 4.889

7.  Inhibition of Rgs10 Expression Prevents Immune Cell Infiltration in Bacteria-induced Inflammatory Lesions and Osteoclast-mediated Bone Destruction.

Authors:  Sen Yang; Liang Hao; Matthew McConnell; Xuedong Zhou; Min Wang; Yan Zhang; John D Mountz; Michael Reddy; Paul D Eleazer; Yi-Ping Li; Wei Chen
Journal:  Bone Res       Date:  2013-09-01       Impact factor: 13.567

8.  Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells.

Authors:  Mei Hong; Yoshihiro Murai; Tomohiko Kutsuna; Hiroyuki Takahashi; Kazuhiro Nomoto; Chun-Mei Cheng; Shin Ishizawa; Qing-Li Zhao; Ryohei Ogawa; Brian V Harmon; Koichi Tsuneyama; Yasuo Takano
Journal:  J Cancer Res Clin Oncol       Date:  2005-09-23       Impact factor: 4.553

Review 9.  Nanoparticles for siRNA-Based Gene Silencing in Tumor Therapy.

Authors:  Anish Babu; Ranganayaki Muralidharan; Narsireddy Amreddy; Meghna Mehta; Anupama Munshi; Rajagopal Ramesh
Journal:  IEEE Trans Nanobioscience       Date:  2016-12       Impact factor: 2.935

10.  Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo.

Authors:  Yoshiko Minakuchi; Fumitaka Takeshita; Nobuyoshi Kosaka; Hideo Sasaki; Yusuke Yamamoto; Makiko Kouno; Kimi Honma; Shunji Nagahara; Koji Hanai; Akihiko Sano; Takashi Kato; Masaaki Terada; Takahiro Ochiya
Journal:  Nucleic Acids Res       Date:  2004-07-22       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.